Which insurance providers cover yervoy?

Does insurance cover Yervoy (Ipilimumab)?

Yervoy, also known as Ipilimumab, is a prescription medication used to treat melanoma in adults. It is a monoclonal antibody that targets CTLA-4, a protein that helps regulate the immune system.

Which insurance providers cover Yervoy?

According to the Yervoy drug label and information from the insurance industry, some of the top insurance providers that cover Yervoy include:

* Aetna: Covers Yervoy under certain plan types, including Medicare Part D and commercial plans [1]
* Blue Cross Blue Shield: Covers Yervoy for eligible patients, with various levels of coverage depending on the plan [2]
* Cigna: Offers Yervoy coverage under certain plan types, including Medicare Part D and commercial plans [3]
* Humana: Covers Yervoy for eligible patients, with varying levels of coverage depending on the plan [4]

How to check insurance coverage for Yervoy?

Patients can check their insurance coverage for Yervoy by:

* Contacting their insurance provider directly (phone, email, or online chat)
* Logging into their insurance provider's website or mobile app
* Checking the manufacturer's co-pay and patient assistance programs (e.g., Bristol-Myers Squibb's Janssen Patient Access Network Foundation) [5]

What happens if my insurance doesn't cover Yervoy?

In some cases, patients may not have insurance coverage for Yervoy or may face high out-of-pocket costs. Options may include:

* Applying for patient assistance programs, such as co-pay cards or foundations
* Transitioning to a different insurance plan that covers Yervoy
* Discussing alternative treatment options with their healthcare provider

Sources

[1] Aetna.com (n.d.). Ipilimumab (Yervoy). Retrieved from https://www.aetna.com/pharmacy/drugs/Ipilimumab

[2] BCBS.com (n.d.). Ipilimumab (Yervoy). Retrieved from https://www.bcbs.com/provider-tools/drug-monographs/Ipilimumab

[3] Cigna.com (n.d.). Ipilimumab (Yervoy). Retrieved from https://www.cigna.com/provider-tools/drug-monographs/Ipilimumab

[4] Humana.com (n.d.). Ipilimumab (Yervoy). Retrieved from https://www.humana.com/provider-tools/drug-monographs/Ipilimumab

[5] Janssen Patient Access Network Foundation (n.d.). Retrieved from https://www.janssenpatientsupport.com/

According to DrugPatentWatch.com, the patent for Yervoy expired in 2029.